Shannon Tsai
About Shannon Tsai
Shannon Tsai is a Drug Formulation & Delivery Co-op currently working at Precision NanoSystems Inc. in Vancouver, British Columbia, with a background in nanotechnology engineering from the University of Waterloo.
Work at Precision NanoSystems
Shannon Tsai currently holds the position of Drug Formulation & Delivery Co-op at Precision NanoSystems Inc. in Vancouver, British Columbia, Canada. She has been in this role since 2021, contributing to the company's initiatives in drug formulation and delivery for three years. Prior to her current position, she worked at the same organization as a Drug Delivery & Formulations Co-op from 2019 to 2020 for seven months. This experience has provided her with a solid foundation in the field of nanotechnology and drug delivery systems.
Education and Expertise
Shannon Tsai studied at the University of Waterloo, where she pursued a Bachelor of Applied Science in Nanotechnology Engineering from 2017 to 2022. Her education provided her with a comprehensive understanding of nanotechnology principles and applications, equipping her with the knowledge necessary for her roles in drug formulation and delivery. This academic background supports her practical experience in the field.
Background in Research and Architecture
Before her current role, Shannon Tsai gained diverse experience through various internships. In 2018, she worked as a Nanophotonics Research Assistant at Frank Gu Lab in Waterloo, Ontario, for three months. Additionally, in 2017, she served as an Architecture Co-op Student at Nick Swerdfeger Architects Inc. in Oshawa, Ontario, for four months. In 2019, she further expanded her research skills as a Research Assistant at the University of Hawaii at Manoa, focusing on design and experiments for three months.
Professional Experience Timeline
Shannon Tsai's professional journey includes multiple roles that have shaped her expertise. She began her co-op experience in 2017 at Nick Swerdfeger Architects Inc. and continued to build her skills in research and development through positions at Frank Gu Lab and the University of Hawaii at Manoa in 2018 and 2019, respectively. Her tenure at Precision NanoSystems began in 2019, where she has since developed her focus on drug formulation and delivery.